E. Santamaría et al. / Journal of Solid State Chemistry 210 (2014) 242–250
243
way that the mesostructure is formed, while the drops of emulsion
will produce the macropores. Emulsions are classified as direct
emulsions or oil in water (O/W), where the continuous phase is
the aqueous one and oil is the dispersed phase, and inverse
emulsions (W/O), where the oil is the continuous phase and the
aqueous phase is the dispersed one.
Cellu-Sep T3/Nominal MWCO: 12,000–14,000 were provided by
Vertex Technics. Deionized water was used in all samples.
2.2. Methods
2.2.1. Ordered meso–macroporous silica material preparation
Ordered meso–macroporous silica materials were prepared
using the emulsion template process. First, water and surfactant
were mixed and kept under stirring at 50 1C to ease the melting of
the surfactant. Later, the dispersed phase, decane, was added drop
by drop until the desired dispersed phase fraction was reached.
Once the emulsion was formed, the sodium silicate solution was
added along with the concentrated HCl to trigger the hydrolysis
reaction of the silicate [15]. The resulting mixture was stirred for
0.5 h and placed in an oven at 100 1C for 24 h to let the silicate
polymerize in the aqueous phase of the emulsion, the external
phase, thus producing a network of ordered mesopores.
The solid product was filtered off and dried at room tempera-
ture. The product was then dispersed in ethanol:HCl (1 M) 1:1
mixture (50 g), filtered off, dried and calcined at 550 1C for 5 h in
order to eliminate the residual surfactant. The final appearance of
the material was a white coloured powder.
In the present work, meso–macroporous materials were pre-
pared via emulsion templating from an inorganic precursor,
sodium silicate, already successfully used by other authors for
the preparation of mesoporous materials [15]. The most com-
monly used sources of silica were TEOS and TMOS, instead of a
sodium silicate solution. Sodium silicate presents advantages:
neither ethanol nor methanol, which could destroy the mesopore
structure, is freed, and they are cheaper than TEOS or TMOS.
Due the stable structure of mesoporous silica and its well-
defined properties, these materials are ideal as a support for drug
and protein encapsulation. In recent years, several researchers
have described the use of mesoporous materials as drug delivery
systems [16–25]. Controlled drug delivery systems can achieve
precise spatial and temporal delivery of therapeutics agents to the
target site. Generally, controlled drug delivery systems maintain
drug concentrations within the optimum range in the precise sites
of the body, which improves the therapeutic efficacy and reduces
toxicity [26]. While smaller drug molecules and biomolecules can
be accommodated in mesoporous materials with both smaller and
bigger pore sizes, larger drug molecules require materials with
bigger pore diameters [27]. Mesoporous silica materials contain
residual silanol groups that can further be functionalized further
by different organic groups in order to modify their surface
properties [28,29]. This creates favourable surface-drug interac-
tions, which in turn results in the materials’ improved adsorption
affinity for drug molecules. Lin and co-workers have shown that
the organic functionalization of mesoporous materials also influ-
ences their biocompatibility [30]. In addition to surface functional
groups, the morphology and size of the mesoporous materials also
have an important influence on drug release characteristics [31].
Generally, surface functionalization of mesoporous silica mate-
rials via covalent bonding of organic groups can be achieved by
two methods. i.e. post-grafting synthesis [29] and co-condensation
[29]. Although the post-grafting method results in well-ordered,
functionalized, mesostructured materials, it often produces non-
uniformly distributed organic groups because the organic moieties
may congregate more on the channel pore mouth and the exterior
surfaces [32]. The co-condensation synthetic method of producing
mesoporous materials involves a one-step procedure and allows
better control of the loading and distribution of organic groups
[33], although it often produces materials with less well-ordered
mesoporous structures. The most frequently studied drug to be
adsorbed is ibuprofen, since it is one of the most commonly used
anti-inflammatory drugs and a model for this drugs type due to its
relatively small size (1 nm).
2.2.2. Material functionalization
2.2.2.1. Post-grafting functionalization process. About 0.9 g of the
material was mixed with 12 mL of APTES and 30 mL of toluene
[34]. The mixture was gently stirred for 24 h and 50 1C in a closed
bottle in order to prevent evaporation. The resulting material was
filtered off and dried at room temperature.
2.2.2.2. Co-condensation functionalization. The material was syn-
thesized as described in Section 2.2.1 and 12 mL of APTES was
added [35] at the same time as the sodium silicate solution. The
resulting mixture was stirred for 0.5 h and placed in an oven at
100 1C for 24 h in order to let the silicate polymerize in the
aqueous phase of the emulsion. The solid product was washed
and filtered off several times in order to eliminate the surfactant
used.
2.2.3. Ibuprofen adsorption process
Typically, 50 mg of the material was put in 5 mL of hexane
containing different concentrations of ibuprofen (IBU) (5, 10, 15, 20
and 35 mg/mL) in a closed bottle to prevent evaporation of the
hexane and under gentle magnetic stirring for 72 h. The concen-
tration of ibuprofen in hexane was determined through an UV
spectrophotometer at 280 nm by collecting 3 mL of hexane filtered
using a syringe filter.
2.2.4. Ibuprofen release experiments
The mesoporous material (100 mg) was placed into 10 mL of
IBU solution in hexane (35 mg/mL) and stirred at room tempera-
ture for 72 h in a closed bottle to prevent evaporation of the
hexane. The loaded materials were then filtered and dried at room
temperature for 24 h. A 50 mg of the resulting materials was put
into a dialysis bag and immersed in 50 mL of simulated body fluid
(SBF, pH 7.4) [36-37] at 37 1C under magnetic stirring at 100 rpm.
2. Materials and methods
2.1. Materials
The triblock copolymer of poly(ethylene oxide)-b-poly(propy-
lene oxide)-b-poly(ethylene oxide) Pluronic P84, (EO)19(PO)39
(EO)19 was supplied by Sigma Aldrich. Sodium silicate solution
(Na2O ꢀ10.6% and SiO2 ꢀ26.5%) was used as a silica source and
was supplied by Sigma Aldrich. Ethanol (96%), HCl (37%), and
potassium cloride and sodium hydroxide were purchased from
Panreac. Ibuprofen (498%) was purchased from TCI Chemicals
Europe. Hexane (95%) and (3-aminopropyl) triethoxysilane
(APTES) (498%) were supplied by Sigma Aldrich. Dialysis bags
2.2.5. Characterization
2.2.5.1. Transmission electron microscopy (TEM). The porous mate-
rial were examined using a TEM (JEOL JEM-2100 microscope with
an acceleration voltage of 200 kV). In order to prepare the sample
for TEM analysis, the material was dispersed in ethanol by
sonication for 5 min. The dispersion was dropped onto a copper
grid coated with carbon film and dried at room temperature.